Follow
Masoud Jamei
Masoud Jamei
Certara UK
Verified email at ieee.org - Homepage
Title
Cited by
Cited by
Year
The Simcyp® Population-based ADME Simulator
M Jamei, S Marciniak, K Feng, A Barnett, G Tucker, A Rostami-Hodjegan
Expert opinion on drug metabolism & toxicology 5 (2), 211-223, 2009
5732009
Population-based mechanistic prediction of oral drug absorption
M Jamei, D Turner, J Yang, S Neuhoff, S Polak, A Rostami-Hodjegan, ...
The AAPS journal 11, 225-237, 2009
4802009
A framework for assessing inter-individual variability in pharmacokinetics using virtual human populations and integrating general knowledge of physical chemistry, biology …
M Jamei, GL Dickinson, A Rostami-Hodjegan
Drug metabolism and pharmacokinetics 24 (1), 53-75, 2009
3852009
Prediction of intestinal first-pass drug metabolism
J Yang, M Jamei, KR Yeo, GT Tucker, A Rostami-Hodjegan
Current drug metabolism 8 (7), 676-684, 2007
3742007
PBPK models for the prediction of in vivo performance of oral dosage forms
ES Kostewicz, L Aarons, M Bergstrand, MB Bolger, A Galetin, O Hatley, ...
European Journal of Pharmaceutical Sciences 57, 300-321, 2014
3282014
Physiologically based pharmacokinetic model qualification and reporting procedures for regulatory submissions: a consortium perspective
M Shebley, P Sandhu, A Emami Riedmaier, M Jamei, R Narayanan, ...
Clinical Pharmacology & Therapeutics 104 (1), 88-110, 2018
2882018
Cytochrome p450 turnover: regulation of synthesis and degradation, methods for determining rates, and implications for the prediction of drug interactions
J Yang, M Liao, M Shou, M Jamei, KR Yeo, GT Tucker, ...
Current drug metabolism 9 (5), 384-393, 2008
2552008
Recent advances in development and application of physiologically-based pharmacokinetic (PBPK) models: a transition from academic curiosity to regulatory acceptance
M Jamei
Current pharmacology reports 2, 161-169, 2016
2382016
ITC recommendations for transporter kinetic parameter estimation and translational modeling of transport‐mediated PK and DDIs in humans
MJ Zamek‐Gliszczynski, CA Lee, A Poirier, J Bentz, X Chu, H Ellens, ...
Clinical Pharmacology & Therapeutics 94 (1), 64-79, 2013
2142013
Physiologically based mechanistic modelling to predict complex drug–drug interactions involving simultaneous competitive and time-dependent enzyme inhibition by parent compound …
KR Yeo, M Jamei, J Yang, GT Tucker, A Rostami-Hodjegan
European Journal of Pharmaceutical Sciences 39 (5), 298-309, 2010
2072010
Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the “Advanced Dissolution, Absorption …
A S Darwich, S Neuhoff, M Jamei, A Rostami-Hodjegan
Current drug metabolism 11 (9), 716-729, 2010
2022010
PBPK modelling of inter-individual variability in the pharmacokinetics of environmental chemicals
FY Bois, M Jamei, HJ Clewell
Toxicology 278 (3), 256-267, 2010
1982010
Misuse of the well-stirred model of hepatic drug clearance
J Yang, M Jamei, KR Yeo, A Rostami-Hodjegan, GT Tucker
Drug Metabolism and Disposition 35 (3), 501-502, 2007
1862007
A mechanistic framework for in vitro–in vivo extrapolation of liver membrane transporters: prediction of drug–drug interaction between rosuvastatin and cyclosporine
M Jamei, F Bajot, S Neuhoff, Z Barter, J Yang, A Rostami-Hodjegan, ...
Clinical pharmacokinetics 53, 73-87, 2014
1762014
Variability in P-glycoprotein inhibitory potency (IC50) using various in vitro experimental systems: implications for universal digoxin drug-drug interaction risk assessment …
J Bentz, MP O’Connor, D Bednarczyk, JA Coleman, C Lee, J Palm, ...
Drug metabolism and disposition 41 (7), 1347-1366, 2013
1682013
Modeling and predicting drug pharmacokinetics in patients with renal impairment
K Rowland Yeo, M Aarabi, M Jamei, A Rostami-Hodjegan
Expert review of clinical pharmacology 4 (2), 261-274, 2011
1622011
Does age affect gastric emptying time? A model‐based meta‐analysis of data from premature neonates through to adults
JJ Bonner, P Vajjah, K Abduljalil, M Jamei, A Rostami‐Hodjegan, ...
Biopharmaceutics & drug disposition 36 (4), 245-257, 2015
1502015
A pregnancy physiologically based pharmacokinetic (p‐PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4
L Gaohua, K Abduljalil, M Jamei, TN Johnson, A Rostami‐Hodjegan
British journal of clinical pharmacology 74 (5), 873-885, 2012
1342012
The simcyp population based simulator: architecture, implementation, and quality assurance
M Jamei, S Marciniak, D Edwards, K Wragg, K Feng, A Barnett, ...
In Silico Pharmacology 1, 1-14, 2013
1292013
In vitro models for the prediction of in vivo performance of oral dosage forms: Recent progress from partnership through the IMI OrBiTo collaboration
J Butler, B Hens, M Vertzoni, J Brouwers, P Berben, J Dressman, ...
European Journal of Pharmaceutics and Biopharmaceutics 136, 70-83, 2019
1162019
The system can't perform the operation now. Try again later.
Articles 1–20